Active Litigation
Breast Mesh Lawsuit Facts
TorHoerman Law is actively accepting claims for the Breast Mesh Lawsuit.
Active Litigation
TorHoerman Law is actively accepting claims for the Breast Mesh Lawsuit.
The AlloMax lawsuit investigation involves allegations concerning postoperative complications following breast reconstruction, revision surgery, and mesh-assisted “internal bra” procedures in which AlloMax acellular dermal matrix (ADM) products were used.
AlloMax and similar surgical mesh products may be used to reinforce tissue, support an implant pocket, or provide additional structural support during breast reconstruction and other procedures.
Reported complications discussed in litigation and medical records may include infection, wound-healing problems, seroma formation, tissue necrosis, implant-related complications, revision surgery, or removal of implants or tissue expanders.
These cases are often evaluated through operative reports, product-identification records, complication timelines, follow-up treatment history, and documentation showing the medical care required after surgery.
TorHoerman Law is reviewing claims involving AlloMax and other mesh or scaffold materials used in implant-based breast procedures where patients later experienced serious postoperative complications.

In implant-based breast reconstruction and some revision procedures, surgeons may use acellular dermal matrix (ADM) products as part of an internal support technique intended to reinforce soft tissue and help stabilize implants or tissue expanders during healing.
AlloMax is one of several ADM products that have been used in these procedures.
The material is intended to function as a supportive scaffold during the postoperative healing process.
Patients who undergo mesh-assisted breast procedures may later experience postoperative complications such as fluid buildup, wound-healing problems, infection, capsular contracture, implant-position changes, chronic pain, or cosmetic deformities requiring additional treatment or revision surgery.
In some cases, complications may involve scar tissue formation, persistent inflammation, tissue breakdown, implant exposure, or changes affecting the shape and support of the reconstructed breast.
Severe postoperative complications may require debridement, implant exchange, implant removal, or additional reconstructive procedures.
Not every complication following breast reconstruction or augmentation surgery is caused by the implanted material itself, and many outcomes depend on the patient’s medical history, tissue quality, surgical technique, healing response, and postoperative course.
Litigation involving AlloMax and other breast mesh products generally focuses on operative records, product identification, complication timelines, revision history, and the medical treatment required after surgery.
If you underwent breast surgery involving AlloMax or another internal support mesh product and later experienced serious postoperative complications, you may wish to speak with a licensed attorney about whether your medical records and treatment history warrant further legal review.
Contact TorHoerman Law today for a free case review.
You can also use the chat feature on this page to get in touch with our lawyers about the breast mesh lawsuit.

Investigations involving AlloMax breast reconstruction lawsuits are part of broader litigation concerning mesh and acellular dermal matrix (ADM) products used in implant-based breast reconstruction, revision procedures, and internal support techniques sometimes referred to as “internal bra” surgery.
These lawsuits generally involve allegations concerning postoperative complications, revision surgery, product labeling, informed consent, complication reporting, and the use of mesh or scaffold materials during breast procedures.
FDA communications issued in 2021 discussed differing complication outcomes reported among certain ADM products used in implant-based breast reconstruction procedures.
Those communications, along with published medical literature and adverse event reporting, are frequently referenced in breast mesh litigation involving postoperative complications such as infection, wound-healing problems, implant loss, seroma formation, capsular contracture, and revision surgery.
FDA communications involving mesh and ADM products have also addressed product labeling, reconstruction outcomes, and the use of mesh materials in implant-based breast procedures.
Manufacturers named in litigation dispute allegations that their products were defective, improperly marketed, or inadequately labeled.
Lawsuits involving AlloMax are may be filed by patients who underwent breast reconstruction, augmentation, revision surgery, or mesh-assisted support procedures and later required additional medical treatment after postoperative complications developed.
Reported complications discussed in litigation may include chronic pain, infection, implant-position problems, wound breakdown, tissue necrosis, fluid collections, cosmetic deformity, implant removal, or additional revision procedures.

Common allegations raised in breast mesh lawsuits may include:
Many patients pursuing breast mesh claims report undergoing additional surgeries, prolonged wound care, implant exchange procedures, or reconstruction revisions following postoperative complications.
Individuals seeking legal review in these cases often pursue compensation related to medical expenses, future treatment needs, lost income, chronic pain, scarring, disfigurement, or other documented damages associated with their postoperative course.
Breast mesh litigation involving AlloMax and other ADM products remains ongoing, and no court has entered findings establishing liability or wrongdoing related to the allegations described in pending lawsuits.
AlloMax is an acellular dermal matrix (ADM) product derived from donated human tissue that has been processed to remove living cells while preserving a collagen-based structural framework.
In implant-based breast reconstruction and some revision procedures, surgeons may use ADM products such as AlloMax to reinforce soft tissue, support the implant pocket, or help stabilize a tissue expander following mastectomy or reconstructive surgery.
Some surgeons also use ADM materials as part of internal support techniques sometimes referred to as “internal bra” procedures, in which the material is positioned within the breast to provide additional structural reinforcement during healing.
AlloMax has been manufactured and distributed by companies associated with C. R. Bard, which later became part of Becton, Dickinson and Company (BD). In lawsuits involving AlloMax, BD is commonly named among the defendants.
ADM products such as AlloMax have been used in a variety of soft-tissue reinforcement procedures, including implant-based breast reconstruction.

FDA communications involving ADM and mesh products have discussed reconstruction outcomes, complication reporting, and product labeling related to implant-based breast procedures.
During healing, ADM materials are intended to function as a supportive scaffold that interacts with surrounding tissue over time.
As with other implant-based breast procedures, some patients later report complications such as infection, wound-healing problems, capsular contracture, implant-position changes, fluid collections, pain, or the need for revision surgery.
Litigation involving AlloMax generally focuses on postoperative complications, revision procedures, product labeling, complication reporting, informed consent, and the medical treatment required after surgery.
In implant-based breast reconstruction, AlloMax may be used to help support a tissue expander or breast implant following mastectomy or revision surgery.
Some plastic surgeons use ADM materials such as AlloMax as part of an internal support technique sometimes referred to as an “internal bra,” where the material is sutured into place to reinforce soft tissue during healing.
AlloMax is one of several acellular dermal matrix products used in implant-based reconstruction and revision procedures involving breast tissue and implant support structures.
Similar techniques may also be used during revision surgery or alongside breast lift procedures to provide additional lower-pole support or reinforce weakened tissue.

AlloMax may be used in several ways during reconstruction or revision procedures, including:
Complications can occur after implant-based breast reconstruction, cosmetic surgery, revision procedures, and other surgeries involving mesh or acellular dermal matrix (ADM) materials.
These materials may be used to support tissue, reinforce an implant pocket, or provide additional structural support during reconstruction or procedures involving internal bra products.
Patients may experience swelling, pain, firmness, wound-healing problems, implant-position changes, or cosmetic concerns during recovery or months after the original procedure.
Postoperative outcomes can depend on factors such as tissue quality, surgical technique, infection risk, radiation exposure, implant placement, and the patient’s overall medical history.
When complications develop, infection, wound breakdown, chronic fluid buildup, scar tissue formation, or tissue damage may affect the implant pocket and surrounding breast tissue.
More severe complications can include skin necrosis or other forms of tissue death caused by impaired blood supply, infection, wound breakdown, or compromised healing.
Some patients require drainage procedures, debridement, prolonged wound care, revision surgery, implant exchange, implant removal, or staged reconstruction after serious complications develop.

Reported complications associated with implant-based breast procedures involving mesh or ADM materials may include:
Not every complication following breast surgery establishes that an ADM or mesh product caused the injury, and many postoperative problems can have multiple contributing factors.
Attorneys generally review operative reports, product-identification records, complication timelines, revision surgery records, and subsequent treatment to determine whether the available evidence supports further investigation.
FDA communications involving surgical mesh and acellular dermal matrix (ADM) products are frequently referenced in breast mesh investigations because they discuss product labeling, complication reporting, and published clinical outcome data involving implant-based breast reconstruction procedures.
FDA communications issued in 2021 and 2023 addressed reconstruction outcomes associated with certain ADM and mesh products used in implant-based breast procedures.
These communications discussed topics including postoperative complications, reoperation rates, implant loss, product labeling, and clinical data reported in published literature and adverse event reporting systems.
The FDA has also issued communications to health care providers regarding labeling updates for certain BD mesh products used for soft-tissue reinforcement applications.
The FDA has not approved Allomax specifically for breast reconstruction.

The communications and patient resources below are among the US Food and Drug Administration (FDA) materials most commonly referenced in litigation and clinical discussions involving mesh-assisted breast procedures:
These FDA communications do not determine whether a specific patient’s postoperative complications were caused by a particular product.
In litigation and claim review, they are typically considered alongside operative reports, pathology findings, complication timelines, revision history, and other medical evidence related to the patient’s treatment course.
You may qualify for an AlloMax breast mesh lawsuit if AlloMax or another acellular dermal matrix (ADM) product was used during breast reconstruction, breast augmentation, revision surgery, or another surgical procedure and you later experienced serious injuries or postoperative complications.
Potential claims are evaluated individually because complications after breast surgery can have multiple causes, and the presence of AlloMax does not by itself establish that the product caused an injury.
Attorneys typically review the type of procedure performed, whether the product was used for general soft tissue reinforcement or internal support, when symptoms developed, and what treatment became necessary afterward.
Claims involving internal bra complications may arise after reconstruction, revision procedures, or lift surgery involving mesh or ADM materials intended to reinforce weakened tissue or support an implant.
Cases may warrant further investigation when patients experience mesh-related complications that result in prolonged treatment, revision surgery, implant failure, implant removal, or other significant consequences.

Circumstances that may be relevant when evaluating AlloMax claims or other internal bra lawsuits include:
Product identification is particularly important because operative reports, implant logs, Unique Device Identifier information, billing records, and pathology records may help establish which ADM or mesh product was used.
If you do not currently have these records, the hospital, surgical center, or treating physician may still maintain documentation that can be requested during a claim review.
Timing can also affect whether a claim may be filed because statutes of limitation differ by state and can depend on when an injury occurred or when a patient discovered the alleged complication.
A breast mesh lawyer can review your medical history, product records, complication timeline, and subsequent treatment to determine whether the available evidence supports further investigation.
Strong evidence is essential in a breast mesh lawsuit because it documents exactly which product was used and how your injuries developed over time.
Medical records, imaging, and operative notes help establish a clear connection between the mesh and the complications you experienced.
To start an internal bra mesh claim, you typically need proof that you received a breast mesh implant, proof of your injuries, and documentation showing the damages you suffered.
A well-supported breast mesh claim is built on records that identify the product, capture the complication timeline, and show what treatment and losses followed.

Evidence in these cases may include:
Damages are the legally recognized losses a person claims after an injury, and they can include both financial costs and the broader impact the complications had on daily life.
In breast mesh lawsuits, damages often reflect the real-world consequences of additional surgeries, extended recovery, and permanent changes to the body.
Breast mesh lawyers review medical records, billing statements, employment documentation, and the treatment timeline to assess what costs have already occurred and what care may be needed going forward.
They also evaluate non-economic harm, including chronic pain, scarring, and emotional distress tied to disfigurement, repeated procedures, or loss of reconstruction outcomes.
The goal is to document damages in a way that is specific, provable, and consistent with the individual’s medical course.

Damages in these cases may include:
Breast mesh implant claims often come down to documentation, a clear medical timeline, and proof of which product was implanted.
When complications lead to infection, tissue loss, revision surgery, or implant removal, the consequences are not theoretical, they show up in operative notes, hospital records, and long-term treatment plans.
TorHoerman Law is investigating breast mesh implant lawsuits involving products used in reconstruction, augmentation, revision, and internal bra procedures, including cases where patients report serious complications after mesh placement.

If you believe a breast mesh implant contributed to your injuries, TorHoerman Law can review your surgical records, complication history, and damages to determine whether the evidence supports a claim.
Contact TorHoerman Law to request a free consultation and learn whether your situation may qualify for legal action.
Reported complications following mesh-assisted breast reconstruction, augmentation, revision surgery, or internal support procedures may include infection, fluid buildup, wound-healing problems, capsular contracture, chronic pain, implant-position changes, cosmetic deformities, and revision surgery.
Mesh and acellular dermal matrix (ADM) materials are used in some implant-based breast procedures to provide additional structural support during healing, but postoperative outcomes can vary depending on the patient’s anatomy, tissue quality, surgical technique, implant placement, infection risk, and other medical factors.
Some patients later require additional treatment such as drainage procedures, washout surgery, implant exchange, revision surgery, or implant removal following postoperative complications.
Not every complication following breast surgery is caused by the implanted material itself, and many outcomes depend on the patient’s overall medical and surgical circumstances.
The fastest way to identify an internal bra mesh implant is to request your operative report and the facility’s implant record from the hospital or surgical center where your procedure was performed.
In mesh assisted breast procedures, surgeons may select products for general soft tissue support and soft tissue reinforcement based on what they believe will integrate best with your anatomy and the surgical plan.
These products can vary widely in material and design, including biologic tissue matrix options made from human or animal tissue and synthetic meshes designed for soft tissue reinforcement.
Because breast mesh manufacturers sell multiple product lines that can look similar in a medical chart, documentation is usually the only reliable way to confirm exactly what you received, especially if you are dealing with chronic inflammation or other long-term complications.
Here’s what to look for in your records:
AlloMax lawsuits are generally treated as part of broader breast mesh litigation rather than a single, finalized global settlement specific to AlloMax.
AlloMax litigation remains active, even as some other manufacturers involved in breast mesh cases have reached settlements in separate litigation tracks.
Because these cases are still developing, the value of individual claims, if any settlements occur, typically depends on the medical evidence, the severity of complications, and the long-term impact on the patient.
Compensation calculations in breast mesh cases typically consider the severity of the injury, the cost and invasiveness of treatment, reduced earning capacity, pain, and the long-term impact on quality of life.
The documentation that tends to matter most includes operative reports, product identification records, treatment notes, and proof of time missed from work or ongoing limitations after complications developed.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Breast Mesh Lawsuit pages listed below:
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.